Clinical Trial

Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening: Advanced Brain Tumor TheRApy Clinical Trial In Patients Scheduled for shOrt Course radiatioN

Study acronym: ATTRACTION
Recruiting
View on ClinicalTrials.gov →
Summary
Patients will receive in addition to standard histology analysis also the PDC- based drug screening.
Trial Details
NCT Number NCT07627334
Lead Sponsor Medical University of Vienna
Conditions Glioblastoma (GBM)
Enrollment 30 participants
Start Date 2026-06-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2029-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-04